CMV DISRUPTION OF CONSTITUTIVE MHC CLASS II
CMV 破坏 MHC II 类结构
基本信息
- 批准号:6626385
- 负责人:
- 金额:$ 26.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-01-01 至 2004-12-31
- 项目状态:已结题
- 来源:
- 关键词:MHC class II antigen actins confocal scanning microscopy cytomegalovirus flow cytometry gene expression genetic library genetic mapping immunofluorescence technique immunoprecipitation intracellular transport latent virus infection microtubules molecular assembly /self assembly plasmids protein folding transfection vesicle /vacuole virus cytopathogenic effect virus infection mechanism virus protein western blottings
项目摘要
DESCRIPTION (Verbatim from the applicant's abstract) Human cytomegalovirus
(CMV) is a significant viral cause of morbidity and mortality in transplant
recipients. In these patients CMV disease often results from reactivation of
latent and persistent virus. A central mechanism of persistence is the ability
of CMV to escape detection by host T lymphocyte-mediated immuno-surveillance,
which is mediated by both CD8+ T lymphocytes and CD4+ T lymphocytes. In an
analogous fashion to CMV encoding multiple genes which disrupt MHC class I, it
now appears that CMV has developed mechanisms to evade CD4+ T lymphocyte
mediated immuno-surveillance through disruption of MHC class II molecule
expression. Within infected cells, CMV inhibits IFN-g induced MHC class II
expression by mechanisms that disrupt the IFN-g signaling pathway. Recently the
effect of CMV on MHC class II expression has been expanded to include
inhibition of constitutively expressed class II, by its gene US2. Using a
constitutive HLA class II expressing cell line, we have found a major
CMV-mediated decrease in surface class II expression that is independent of US2
or proteasomal degradation. Our Northern, Western and confocal microscopy
studies suggest that the mechanism is a defect in trafficking of mature class
II to the cell surface. Moreover, this mechanism specifically targets class II,
since studies with mutant CMV lacking the genes that alter class I demonstrate
normal to increased class I expression, but decreased class II surface
expression. Based on our preliminary data, we will test the hypothesis that CMV
specifically blocks class II trafficking by altering the intracellular vesicle
trafficking machinery. In Specific Aim I, we will further characterize the
effect of CMV infection on MHC class II expression. The transport and assembly
of MHC class II molecules in infected cells will be examined using
co-immunoprecipitation, Western blot analyses, and confocal microscopy. In
Specific Aim II, the mechanism(s) of the CMV-mediated decrease in constitutive
MHC class II expression will be investigated, specifically examining the role
of CMV-mediated disruption of the actin and microtubule networks in this
inhibition. We will quantify the effect of CMV on the polymerization, cleavage
and integrity of these structures and determine the mechanism(s) CMV uses to
inhibit their ability to traffic class II positive vesicles. In Specific Aim
III, stable transfections of the U373-CIITA line with CMV Towne strain cosmid
clones will be used, in conjunction with a CMV cDNA library, to identify and
isolate the CMV genes responsible for the decrease in constitutive MHC class II
surface expression.
描述(来自申请人摘要的逐字描述)人巨细胞病毒
(CMV)是移植中发病率和死亡率重要病毒原因
受惠人士在这些患者中,CMV疾病通常是由于
潜伏和持久病毒。坚持的核心机制是
CMV逃避宿主T淋巴细胞介导的免疫监视的检测,
其由CD 8 + T淋巴细胞和CD 4 + T淋巴细胞介导。中
与编码破坏MHC I类的多个基因的CMV类似,
现在看来,CMV已经开发出了逃避CD 4 + T淋巴细胞的机制,
通过破坏MHC II类分子介导的免疫监视
表情在感染的细胞内,CMV抑制IFN-γ诱导的MHC II类
通过破坏IFN-g信号通路的机制表达。最近
CMV对MHCII类表达的影响已经扩大到包括
通过其基因US 2抑制组成型表达的II类。使用
组成型HLA II类表达细胞系,我们已经发现了一个主要的
CMV介导的不依赖于US 2的表面II类蛋白表达降低
或蛋白酶体降解。我们的北方、西方和共聚焦显微镜
研究表明,成熟类的贩运机制存在缺陷
II至细胞表面。此外,这一机制专门针对第二类,
由于缺乏改变I类基因的突变CMV的研究表明,
I类表达正常至增加,但II类表面减少
表情根据我们的初步数据,我们将测试CMV
通过改变胞内囊泡特异性阻断II类转运
贩卖机器在具体目标I中,我们将进一步描述
CMV感染对MHC II类分子表达影响。所述运输及组装
在感染细胞中的MHC II类分子将被检查,
免疫共沉淀、Western印迹分析和共聚焦显微镜。在
具体目标II,CMV介导的组成性降低的机制
将研究MHC II类表达,特别是研究其作用。
CMV介导的肌动蛋白和微管网络的破坏,
抑制作用我们将量化CMV对聚合、裂解和降解的影响,
这些结构的完整性,并确定CMV用于
抑制其运输II类阳性囊泡的能力。具体目标
III,用CMV Towne株粘粒稳定转染U373-CIITA系
克隆将与CMV cDNA文库结合使用,以鉴定和
分离导致组成型MHC II类减少的CMV基因,
表面表达
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William James Waldman其他文献
William James Waldman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William James Waldman', 18)}}的其他基金
Endothelial-reactive antibodies: a diagnostic test for Susac's syndrome
内皮反应性抗体:苏萨克综合征的诊断测试
- 批准号:
8048660 - 财政年份:2010
- 资助金额:
$ 26.26万 - 项目类别:
Endothelial-reactive antibodies: a diagnostic test for Susac's syndrome
内皮反应性抗体:苏萨克综合征的诊断测试
- 批准号:
8133697 - 财政年份:2010
- 资助金额:
$ 26.26万 - 项目类别:
Antiviral activity of leflunomide against respiratory syncytial virus
来氟米特对呼吸道合胞病毒的抗病毒活性
- 批准号:
7908439 - 财政年份:2009
- 资助金额:
$ 26.26万 - 项目类别:
Antiviral activity of leflunomide against respiratory syncytial virus
来氟米特对呼吸道合胞病毒的抗病毒活性
- 批准号:
7679336 - 财政年份:2008
- 资助金额:
$ 26.26万 - 项目类别:
ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
免疫抑制剂来氟米特的抗病毒活性
- 批准号:
6708845 - 财政年份:2001
- 资助金额:
$ 26.26万 - 项目类别:
ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
免疫抑制剂来氟米特的抗病毒活性
- 批准号:
6287600 - 财政年份:2001
- 资助金额:
$ 26.26万 - 项目类别:
CMV DISRUPTION OF CONSTITUTIVE MHC CLASS II
CMV 破坏 MHC II 类结构
- 批准号:
6690776 - 财政年份:2001
- 资助金额:
$ 26.26万 - 项目类别:
ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
免疫抑制剂来氟米特的抗病毒活性
- 批准号:
6632026 - 财政年份:2001
- 资助金额:
$ 26.26万 - 项目类别:
ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
免疫抑制剂来氟米特的抗病毒活性
- 批准号:
6510888 - 财政年份:2001
- 资助金额:
$ 26.26万 - 项目类别:
CMV/IMMUNE INTERACTIONS IN TRANSPLANT ARTERIOSCLEROSIS
移植动脉硬化中巨细胞病毒/免疫相互作用
- 批准号:
6030747 - 财政年份:1996
- 资助金额:
$ 26.26万 - 项目类别:
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 26.26万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
342887 - 财政年份:2016
- 资助金额:
$ 26.26万 - 项目类别:
Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
278338 - 财政年份:2013
- 资助金额:
$ 26.26万 - 项目类别:
Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
- 批准号:
8505938 - 财政年份:2012
- 资助金额:
$ 26.26万 - 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
- 批准号:
7931495 - 财政年份:2009
- 资助金额:
$ 26.26万 - 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
- 批准号:
19390048 - 财政年份:2007
- 资助金额:
$ 26.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
- 批准号:
5311554 - 财政年份:2001
- 资助金额:
$ 26.26万 - 项目类别:
Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 26.26万 - 项目类别: